Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA.
Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA.
Vaccine. 2021 Jan 15;39(3):469-472. doi: 10.1016/j.vaccine.2020.11.075. Epub 2020 Dec 19.
We evaluated the effectiveness of anti-22F serotype immunity in the prevention of Streptococcus pneumoniae (Spn) bacterial transmission during colonization and influenza virus co-infection. Mice were immunized with 22F formulation and later colonized with Spn or co-infected with Spn and influenza virus. The 22F antisera exhibited strong reactivity to 22F bacteria and promoted the opsonic uptake of Spn by the neutrophils. The 22F vaccination led to a significant reduction of bacterial densities in the nasopharynx and prevented bacterial transmission during colonization and co-infection. The transfer of 22F antisera to infant mice resulted in reduced bacterial transmission in colonization and co-infection models.
我们评估了抗 22F 血清型免疫在预防定植和流感病毒共感染期间肺炎链球菌(Spn)细菌传播中的有效性。小鼠用 22F 制剂免疫,随后用 Spn 定植或 Spn 和流感病毒共感染。22F 抗血清对 22F 细菌表现出强烈的反应性,并促进中性粒细胞对 Spn 的调理摄取。22F 疫苗接种可显著降低鼻咽部的细菌密度,并防止定植和共感染期间细菌传播。将 22F 抗血清转移到婴儿小鼠中可减少定植和共感染模型中的细菌传播。